Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
375 |
|
Actual shortage: | 28 (7%) | |
Anticipated shortage: | 2 (1%) | |
Avoided shortage: | 6 (2%) | |
Resolved: | 339 (90%) | |
Discontinuation Reports |
58 |
|
To be discontinued: | 1 (2%) | |
Discontinued: | 55 (95%) | |
Reversed: | 2 (3%) | |
Late reports |
29 (7%) |
|
Overdue reports |
14 (45%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
AA-FENO-SUPER | 100MG | TABLET | Resolved | 2021-06-25 | 2022-02-23 | 141529 |
AA-FENO-SUPER | 100MG | TABLET | Resolved | 2021-09-09 | 2021-09-24 | 145407 |
AA-FENO-SUPER | 100MG | TABLET | Resolved | 2024-01-31 | 2024-03-21 | 217948 |
AA-FENO-SUPER | 160MG | TABLET | Resolved | 2017-03-20 | 2018-05-15 | 3524 |
AA-FENO-SUPER | 160MG | TABLET | Resolved | 2017-05-02 | 2017-08-29 | 8593 |
AA-FENO-SUPER | 160MG | TABLET | Resolved | 2018-05-15 | 2018-08-27 | 49362 |
AA-FENO-SUPER | 160MG | TABLET | Resolved | 2019-05-08 | 2019-08-19 | 83502 |
AA-FENO-SUPER | 160MG | TABLET | Resolved | 2021-01-22 | 2021-01-26 | 132352 |
AA-FENO-SUPER | 160MG | TABLET | Resolved | 2021-09-15 | 2021-09-24 | 145663 |
AA-FENO-SUPER | 160MG | TABLET | Resolved | 2024-02-08 | 2024-03-21 | 219018 |
AA-ATENIDONE | 25MG 50MG | TABLET | Resolved | 2018-03-20 | 2018-07-23 | 43498 |
AA-ATENIDONE | 25MG 50MG | TABLET | Resolved | 2019-01-15 | 2019-02-21 | 72351 |
AA-ATENIDONE | 25MG 100MG | TABLET | Resolved | 2018-04-10 | 2018-07-23 | 45331 |
HYDROXYZINE | 50MG | CAPSULE | Resolved | 2017-05-24 | 2017-09-22 | 11072 |
HYDROXYZINE | 50MG | CAPSULE | Resolved | 2018-01-17 | 2018-04-09 | 36288 |
HYDROXYZINE | 50MG | CAPSULE | Resolved | 2019-04-29 | 2019-08-22 | 82756 |
HYDROXYZINE | 50MG | CAPSULE | Resolved | 2019-11-08 | 2019-12-06 | 98246 |
HYDROXYZINE | 50MG | CAPSULE | Resolved | 2022-05-06 | 2022-06-23 | 160167 |
HYDROXYZINE | 50MG | CAPSULE | Resolved | 2022-12-01 | 2023-06-23 | 176660 |
HYDROXYZINE | 50MG | CAPSULE | Resolved | 2023-06-29 | 2023-08-14 | 196837 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
FENOFIBRATE | Discontinued | 2019-01-03 | 2019-01-03 | 70900 | ||
TICLOPIDINE | 250MG | TABLET | Discontinued | 2019-04-01 | 2019-04-02 | 80166 |
DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
ISDN | 5MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108370 |
ORCIPRENALINE | 2MG | SYRUP | Discontinued | 2020-03-10 | 2020-03-11 | 108373 |
ERYTHRO-S | 250MG | TABLET | Discontinued | 2020-07-28 | 2020-07-29 | 121300 |
PONSTAN | 250MG | CAPSULE | Discontinued | 2020-07-28 | 2020-07-29 | 121303 |
ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |
IPRAVENT | 21MCG | SOLUTION | Discontinued | 2020-08-06 | 2020-08-06 | 121828 |
KETOPROFEN | 50MG | CAPSULE | Discontinued | 2020-08-06 | 2020-08-06 | 121831 |
ORAP | 2MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121834 |
ORAP | 4MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121837 |
CHLORAX | 2.5MG 5MG | CAPSULE | Discontinued | 2022-01-20 | 2022-01-21 | 153244 |
ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
TRIHEXYPHENIDYL | 2MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70209 |
TRIHEXYPHENIDYL | 5MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70212 |
CIMETIDINE | 300MG | TABLET | To be discontinued | 2019-01-02 | 2019-01-02 | 70796 |